Rotop - Dmsa
Product Images NDC 71647-001

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rotop - Dmsa (NDC 71647-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rotop Pharmaka Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rotop Dmsa 01

Chemical structure diagram labeled as the structural formula of the active ingredient in ROTOP - DMSA, showing two carbon atoms each bonded to a thiol group (SH) and carboxyl groups (COOH).*

FDA Label Image

Rotop Dmsa 02

Label for ROTOP - DMSA 1.0 mg, a kit for radiopharmaceutical preparation by ROTOP Pharmaka GmbH. It contains 1.74 mg powder for solution for injection, intended for intravenous use after reconstitution and labeling. The label specifies use in infants, children, and adults, and includes spaces for lot and expiration information.*

FDA Label Image

Rotop Dmsa 03

ROTOP - DMSA 1.0 mg kit for radiopharmaceutical preparation containing succimer powder for solution for injection. The label indicates 5 vials, each with 1.74 mg powder including 1.0 mg succimer active substance. Manufactured by ROTOP Pharmaka GmbH, Germany, with storage instructions to refrigerate at 2-8°C and keep out of reach of children.*

FDA Label Image

Rotop Dmsa 04

Label for ROTOP - DMSA 1.0 mg, a kit for radiopharmaceutical preparation by ROTOP Pharmaka GmbH. It includes 1.74 mg powder for solution for injection, intended for intravenous use after reconstitution and labeling. Suitable for infants, children, and adults. The label also features placeholders for lot and expiration dates.*

FDA Label Image

Rotop Dmsa 05

ROTOP - DMSA 1.0 mg vial label for radiopharmaceutical preparation containing succimer. The label indicates 5 vials each with 1.74 mg powder for solution for injection, including 1.0 mg succimer as active substance. Packaging includes storage instructions, manufacturer ROTOP Pharmaka GmbH, Dresden, Germany, and cautions for use in infants, children, and adults.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.